Inventor · disambiguated record
Kevin Smith
Also filed as: SMITH KEVIN · SMITH KEVIN J · SMITH KEVIN JOHN
12 granted patents·20 pending applications·1,204 citations·filing 1994–2023
94Inventor score
Files withEURO CELTIQUE SA17PURDUE PHARMA LP6HARM REDUCTION THERAPEUTICS INC3LEYENDECKER PETRA2LTS LOHMANN THERAPIE SYSTEME AG2
Top patents by PatentIndex Score
32 records- 0198US5879705ASustained release compositions of morphine and a method of preparing pharmaceutical compositionsEURO CELTIQUE SA·Filed 1997·Granted Mar 9, 1999·322 cites·11 claims
- 0297US6326027B1Controlled release formulationEURO CELTIQUE SA·Filed 1995·Granted Dec 4, 2001·180 cites·46 claims
- 0397US6254887B1Controlled release tramadolEURO CELTIQUE SA·Filed 1996·Granted Jul 3, 2001·219 cites·33 claims
- 0497US5591452AControlled release formulationEURO CELTIQUE SA·Filed 1994·Granted Jan 7, 1997·260 cites·39 claims
- 0596US7074430B2Controlled release tramadol tramadol formulationEURO CELTIQUE SA·Filed 2001·Granted Jul 11, 2006·95 cites·17 claims
- 0692US11020343B2Intranasal pharmaceutical dosage forms comprising naloxoneHARM REDUCTION THERAPEUTICS INC·Filed 2019·Granted Jun 1, 2021·7 cites·13 claims
- 0792US6143328ASustained release compositions and a method of preparing pharmaceutical compositionsEURO CELTIQUE SA·Filed 1999·Granted Nov 7, 2000·108 cites·13 claims
- 0890US11806428B2Intranasal pharmaceutical dosage forms comprising naloxoneHARM REDUCTION THERAPEUTICS INC·Filed 2021·Granted Nov 7, 2023·2 cites·35 claims
- 0987US9549903B2Transdermal delivery system comprising buprenorphinePURDUE PHARMA LP·Filed 2016·Granted Jan 24, 2017·11 cites·28 claims
- 1084US12458591B2Intranasal pharmaceutical dosage forms comprising naloxoneHARM REDUCTION THERAPEUTICS INC·Filed 2023·Granted Nov 4, 2025·0 cites·17 claims
- 1165US2009117191A1Controlled release tramadol formulationsPURDUE PHARMA PRODUCTS L P·Filed 2008·Application pending·0 cites
- 1264US10898479B2Dihydroetorphine for the provision of pain relief and anaesthesiaEURO CELTIQUE SA·Filed 2014·Granted Jan 26, 2021·0 cites·32 claims
- 1361US2020306204A1Transdermal delivery system comprising buprenorphineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
- 1460US2006269603A1Controlled release tramadol formulationsEURO CELTIQUE SA·Filed 2006·Application pending·0 cites
- 1560US2017304192A1Intranasal pharmaceutical dosage forms comprising naloxoneEURO CELTIQUE SA·Filed 2017·Application pending·0 cites
- 1659US2020253957A1Transdermal delivery systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
- 1759US2017231904A1Intranasal Pharmaceutical Dosage Forms Comprising NaloxoneEURO CELTIQUE SA·Filed 2017·Application pending·0 cites
- 1857US2015018379A1Intranasal Pharmaceutical Dosage Forms Comprising NaloxoneEURO CELTIQUE SA·Filed 2012·Application pending·0 cites
- 1957US2021085673A1Dihydroetorphine for the provision of pain relief and anaesthesiaEURO CELTIQUE SA·Filed 2020·Application pending·0 cites
- 2055US2014031382A1Dosage form containing oxycodone and naloxoneEURO CELTIQUE SA·Filed 2013·Application pending·0 cites
- 2154US2015126540A1Intranasal Pharmaceutical Dosage Forms Comprising NaloxoneEURO CELTIQUE SA·Filed 2015·Application pending·0 cites
- 2253US2018008593A1Dosage form containing oxycodone and naloxonePURDUE PHARMA LP·Filed 2017·Application pending·0 cites
- 2352US2014363487A1Transdermal delivery system comprising buprenorphinePURDUE PHARMA LP·Filed 2012·Application pending·0 cites
- 2451US2015306093A1Transdermal delivery systemPURDUE PHARMA LP·Filed 2013·Application pending·0 cites
- 2550US2017049713A1Transdermal delivery system comprising buprenorphinePURDUE PHARMA LP·Filed 2016·Application pending·0 cites
- 2650US2018193333A1Transdermal delivery systemPURDUE PHARMA LP·Filed 2018·Application pending·0 cites
- 2749US2011172259A1Dosage form containing oxycodone and naloxoneEURO CELTIQUE SA·Filed 2010·Application pending·0 cites
- 2846US2008145429A1Dosage Form Containing Oxycodone and NaloxoneLEYENDECKER PETRA·Filed 2006·Application pending·0 cites
- 2944US2012225901A1Dosage form containing oxycodone and naloxoneLEYENDECKER PETRA·Filed 2011·Application pending·0 cites
- 3043US9782359B2Opioid composition for treating skin lesionsOKSCHE ALEXANDER·Filed 2009·Granted Oct 10, 2017·0 cites·33 claims
- 3140US2018221299A1Transdermal delivery systemEURO CELTIQUE SA·Filed 2016·Application pending·0 cites
- 3240US2018221298A1Transdermal delivery systemEURO CELTIQUE SA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →